Welcome
 

GMO is a global investment management firm committed to providing sophisticated clients with superior asset management solutions and services. We offer a broad range of investment products, including equity and fixed income strategies across global developed and emerging markets, as well as absolute return strategies. Our client base includes endowments, pension funds, public funds, foundations and cultural institutions.

GMO is a private partnership that employs more than 550 people worldwide. Investment management is our only business. As of March 31, 2014, we managed $118 billion in client assets, $55 billion of which was in asset allocation strategies.

Our global offices include the firm's headquarters in Boston and offices in San Francisco, London, Amsterdam, Zurich, Singapore, and Sydney. For more information on GMO, please see About GMO.

To read GMO's 2Q 2014 Letter, which contains Ben Inker's "Free Lunches and the Food Truck Revolution," and Jeremy Grantham's "Summer Essays, Volume 2," please click the blue highlighted link.

(To open file, please ensure you have the most recent version of Acrobat Reader installed.)

Other recent commentary available to the public can be found by clicking on the links below:
A Farmland Investment Primer  -- Julie Koeninger
Investing for Retirement: The Defined Contribution Challenge  -- Ben Inker and Martin Tarlie
A CAPE Crusader: A Defence Against the Dark Arts  -- James Montier
No Silver Bullets in Investing (just old snake oil in new bottles)  -- James Montier
Present and Emerging Risks to the Gold Trade  -- Amit Bhartia and Matt Seto
Health Is Wealth: Health Care Spending As An Emerging Market Growth Engine  -- Amit Bhartia and Alvaro Pascual
Hyperinflations, Hysteria, and False Memories  -- James Montier
Feeding the Dragon: Why China's Credit System Looks Vulnerable  -- Edward Chancellor and Mike Monnelly
In order to view other selected market commentary, please register with our website. Registering also gives you access to information about GMO's strategies as well as the GMO Trust Prospectus, Statement of Additional Information, and annual and semi-annual reports.